益诺思：控股子公司拟进行业务调整

格隆汇资讯2025-06-24

格隆汇6月24日丨益诺思(688710.SH)公布，为优化产能配置，降低管理成本，提高管理效率和管控能力，结合公司控股子公司深圳市益诺思生物医药安全评价研究院有限公司(以下简称“深圳益诺思”)实际经营情况，深圳益诺思将进行业务调整，除存续业务以外不再承接新业务;同时公司募集资金投资项目(以下简称“募投项目”)已按计划顺利推进，全资子公司益诺思生物技术南通有限公司(以下简称“南通益诺思”)所实施的募...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2545289248?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2025-06-24 18:52","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2545289248","market":"sh","top_or_hot":-1,"title":"益诺思：控股子公司拟进行业务调整","media":"格隆汇资讯","content":"<div>\n<p>格隆汇6月24日丨益诺思(688710.SH)公布，为优化产能配置，降低管理成本，提高管理效率和管控能力，结合公司控股子公司深圳市益诺思生物医药安全评价研究院有限公司(以下简称“深圳益诺思”)实际经营情况，深圳益诺思将进行业务调整，除存续业务以外不再承接新业务;同时公司募集资金投资项目(以下简称“募投项目”)已按计划顺利推进，全资子公司益诺思生物技术南通有限公司(以下简称“南通益诺思”)所实施的募...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250624185239978cb955&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>益诺思：控股子公司拟进行业务调整</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n益诺思：控股子公司拟进行业务调整\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-06-24 18:52 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250624185239978cb955&s=b><strong>格隆汇资讯</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>格隆汇6月24日丨益诺思(688710.SH)公布，为优化产能配置，降低管理成本，提高管理效率和管控能力，结合公司控股子公司深圳市益诺思生物医药安全评价研究院有限公司(以下简称“深圳益诺思”)实际经营情况，深圳益诺思将进行业务调整，除存续业务以外不再承接新业务;同时公司募集资金投资项目(以下简称“募投项目”)已按计划顺利推进，全资子公司益诺思生物技术南通有限公司(以下简称“南通益诺思”)所实施的募...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250624185239978cb955&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"688710","symbol_name":"益诺思","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250624185239978cb955&s=b","article_id":"2545289248","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250624185239978cb955&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2545289248","pubTimestamp":1750762340,"columns":[],"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"格隆汇6月24日丨益诺思(688710.SH)公布，为优化产能配置，降低管理成本，提高管理效率和管控能力，结合公司控股子公司深圳市益诺思生物医药安全评价研究院有限公司(以下简称“深圳益诺思”)实际经营情况，深圳益诺思将进行业务调整，除存续业务以外不再承接新业务;同时公司募集资金投资项目(以下简称“募投项目”)已按计划顺利推进，全资子公司益诺思生物技术南通有限公司(以下简称“南通益诺思”)所实施的募投项目“高品质非临床创新药物综合评价平台扩建项目”将逐步投入使用，后续新增业务将由上海益诺思及南通益诺思承接。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"688710":"益诺思","BK0216":"研究试验"},"translate_title":"Yinuosi: Holding subsidiary plans to make business adjustments","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"688710":1},"content_text":"格隆汇6月24日丨益诺思(688710.SH)公布，为优化产能配置，降低管理成本，提高管理效率和管控能力，结合公司控股子公司深圳市益诺思生物医药安全评价研究院有限公司(以下简称“深圳益诺思”)实际经营情况，深圳益诺思将进行业务调整，除存续业务以外不再承接新业务;同时公司募集资金投资项目(以下简称“募投项目”)已按计划顺利推进，全资子公司益诺思生物技术南通有限公司(以下简称“南通益诺思”)所实施的募投项目“高品质非临床创新药物综合评价平台扩建项目”将逐步投入使用，后续新增业务将由上海益诺思及南通益诺思承接。","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2545289248","isCrawlerRequest":true}